OFD1P7Y

Across TCGA pan-cancer cohorts, OFD1P7Y RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OFD1P7Y data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OFD1P7Y RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OFD1P7Y expression acts as an unfavorable survival marker.

STAD, COAD, and KIRP are the cancer types where OFD1P7Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.121	0.397	<.001	90	view →
COAD	OS	Tertile	All	0.140	0.806	<.001	90	view →
KIRP	OS	Tertile	All	0.111	0.897	<.001	72	view →
UCEC	OS	Tertile	All	0.224	0.873	<.001	72	view →
THCA	DFS	Tertile	II,III,IV	0.144	0.878	<.001	57	view →
PAAD	OS	Tertile	All	0.138	0.590	<.001	36	view →
LUSC	OS	Tertile	III,IV	0.047	0.684	<.001	36	view →
BRCA	OS	Tertile	III,IV	0.514	0.907	<.001	30	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OFD1P7Y–STAD (DFS)

Open the STAD breakdown →